PET-study on the Role of the Reward System in Weight Loss After Bariatric Surgery
ObesiPET
1 other identifier
interventional
30
1 country
1
Brief Summary
Bariatric surgery (BS) is currently the most effective treatment in severe obesity. However, a considerable percentage of patients undergoing BS fail to lose sufficient weight or regain weight after initial weight loss during long-term follow-up, which may be attributed to personality traits and pathological eating behaviour. Previous positron emission tomography (PET) studies have shown reduced dopamine D2 receptor availability in obese patients and upregulation of this availability following successful BS in the brain's reward system. Dopamine D2 receptor availability in patients with unsuccessful BS has not been investigated to date.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Dec 2022
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2022
CompletedFirst Posted
Study publicly available on registry
May 4, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 29, 2026
April 1, 2026
4.1 years
April 12, 2022
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in [11C]-raclopride binding potential in the brain's reward system between study groups before and after a food challenge.
Pre- and post-eating changes in dopamine D2 receptor availability as indexed by the \[11C\]-raclopride binding potential in the brain's reward system between subjects who underwent successful vs unsuccessful bariatric surgery
-50 minutes (before start of PET scanning), 0 minutes (during PET break, before mixed meal), 30 minutes (after second phase of PET-scanning)
Secondary Outcomes (2)
The correlation between [11C]-raclopride binding potential in the brain's reward system and of questionnaires and diaries
Pre-intervention
The correlation between [11C]-raclopride binding potential in the brain's reward system and of gut hormones.
-50 minutes (before start of PET scanning), 0 minutes (during PET break, before mixed meal), 30 minutes (after second phase of PET-scanning), 60 - 90 - 120 minutes
Study Arms (2)
Unsuccessful BS (Total Weight Loss (TWL) < 20%)
EXPERIMENTALFifteen who had unsuccessful BS (Total Weight Loss (TWL) \< 20%)
Successful BS (TWL > 25%).
EXPERIMENTALFifteen who had successful BS (TWL \> 25%).
Interventions
Administration of food in controlled situation
Eligibility Criteria
You may qualify if:
- Bariatric surgery 24-36 months prior to the study
- Adult (over 18y old)
- Mentally capable to understand the consequences of the procedure and make his or her own choice without coercion
- Able to undergo PET and MRI, according to the investigator's assessment
- Native speaking
- Able to participate in follow-up
- Written informed consent
You may not qualify if:
- Presence of a DSM-IV axis 1 disorder
- The use of drugs that bind to dopamine D2/3 receptors, including various classes of antipsychotics and antidepressants
- History of stroke, brain tumor, Parkinson's Disease or dementia
- History of head trauma with loss of consciousness
- Alcohol or substance abuse in the last 6 months
- Alcohol consumption 24h prior to PET scanning
- Smoking or other forms of nicotine intake 12 hours prior to PET scanning
- Use of anorectic drugs in the last 6 months
- Current pregnancy
- Medication for Diabetes Mellitus
- Claustrophobia
- The presence of implanted metal objects of the type which may concentrate radiofrequency fields or cause tissue damage from twisting in a magnetic field (such as certain implanted devices, shrapnel, ocular metal shavings)
- Patients with a bodyweight \> 200kg will be excluded to ensure the maximum load of the camera bed of the PET-scanner (227 kg) is not exceeded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MCL
Leeuwarden, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2022
First Posted
May 4, 2022
Study Start
December 1, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share